10 articles
Paradromics announced on 17 June 2026 that University of Michigan surgeons have implanted its Connexus brain-computer interface in a woman with motor neuron disease, the first patient in the FDA-approved Connect-One early feasibility study. She will be followed for six years.
Casey Harrell, who has ALS, used a UC Davis intracortical speech BCI at home for more than 3,800 hours over 22 months without researchers present. Nature Medicine published the case on 15 June 2026.
Yale's Nature Neuroscience study reports that healthy participants learned to control a video game avatar in under an hour when the fMRI decoder followed each user's individual neural manifold. Off-manifold mappings produced no learning at all.
A KU Leuven team led by Peter Janssen trained three rhesus macaques to pilot avatars through virtual environments using implanted multi-array BCIs, with premotor cortex outperforming primary motor cortex and a single fixed decoder generalising across perspectives, avatars, and dynamic targets.
Michel Maharbiz departed iota Biosciences on 1 April and has emerged with a San Francisco BCI startup targeting post-stroke upper-limb rehabilitation, with a 64-channel epidural array, motorised glove, first-in-human at Lenox Hill later this year, and an FDA submission targeted for February 2027.
A Mark Hersam-led team at Northwestern has demonstrated aerosol-jet-printed neuromorphic devices that generate biologically realistic voltage spikes and trigger responses in mouse cerebellum slices, a first for printed electronics and a potential route to lower-cost, flexible neural interfaces.
The Barcelona neurotechnology enrolled ten patients and implanted eight during brain tumour resection at Salford Royal Hospital, completing the first human cohort for any graphene-based neural interface. Full results due later in 2026.
The Eindhoven-listed neurotech priced a private placement at €3.00 per share, led by EQT Life Sciences, to expand ARC-EX commercial operations and advance ARC-IM through regulatory work. Cash runway extends into Q1 2028.
Galen Buckwalter, a quadriplegic research psychologist with six Utah arrays in his brain, is using a Caltech-developed interface to generate music directly from neural signals.
FDA grants approval for Neuralink to enroll significantly more participants in its brain-computer interface clinical trials, marking a major step toward commercialization.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.